PharVision Advisers’s Ross Stores ROST Stock Holding History

PharVision Advisers’s Portfolio ROST Stock Details ROST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,508	Closed	-$272K	–	536
2025 Q4	$272K	Buy	+1,508	New	+$252K	0.14%	336

Other funds holding ROST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PharVision Advisers's ROST Position: Q1 2026 in Review

PharVision Advisers sold out of Ross Stores (ROST) in Q1 2026, closing a stake of 1,508 shares — an estimated $272K sold.

PharVision Advisers first reported a position in ROST in Q4 2025 and held it in 1 quarter. The position peaked at $272K in Q4 2025. 1,359 funds tracked by Wall St. Rank hold ROST as of Q1 2026.

PharVision Advisers reported no remaining Ross Stores position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 1,508 Ross Stores shares in Q1 2026, an estimated $272K.
PharVision Advisers first reported a position in Ross Stores in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Ross Stores position peaked at $272K in Q4 2025.
1,359 funds tracked by Wall St. Rank held Ross Stores as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.